Mark Arnold Hagler insider trades

Open-market stock purchases and sales by Mark Arnold Hagler, Chief Commercial Officer at NovaBridge Biosciences, from SEC Form 4 filings since Apr 24, 2026.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -39%.

Recent trades

DateStockTradeValue
Jul 8, 2026NBP NovaBridge BiosciencesBought (not open market)—
Apr 24, 2026NBP NovaBridge BiosciencesBought$577K

Companies traded

  • NBP NovaBridge Biosciences: 1 buy, last Jul 8, 2026

Get free alerts when Mark Arnold Hagler files a new trade →